tradingkey.logo

Insulet Corp

PODD
241.930USD
-1.220-0.50%
종가 02/06, 16:00ET시세는 15분 지연됩니다
17.02B시가총액
69.05P/E TTM

Insulet Corp

241.930
-1.220-0.50%

자세한 내용은 Insulet Corp 회사

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Insulet Corp 정보

종목 코드 PODD
회사 이름Insulet Corp
상장일May 15, 2007
CEOMcevoy (Ashley)
직원 수3900
유형Ordinary Share
회계 연도 종료May 15
주소100 Nagog Park
도시ACTON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호01720-3440
전화19786007000
웹사이트https://www.omnipod.com
종목 코드 PODD
상장일May 15, 2007
CEOMcevoy (Ashley)

Insulet Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
27.70K
+778.00%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
14.85K
-1380.00%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
10.47K
-4263.00%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
5.24K
+778.00%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
5.22K
+759.00%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
3.85K
+962.00%
Mr. Prem Singh
Mr. Prem Singh
Senior Vice President - Global Operations
Senior Vice President - Global Operations
3.56K
-687.00%
Ms. Laetitia Cousin
Ms. Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
3.44K
-140.00%
Dr. Luciana Borio, M.D.
Dr. Luciana Borio, M.D.
Independent Director
Independent Director
3.09K
-481.00%
Mr. Timothy J. (Tim) Scannell
Mr. Timothy J. (Tim) Scannell
Independent Chairman of the Board
Independent Chairman of the Board
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
27.70K
+778.00%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
14.85K
-1380.00%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
10.47K
-4263.00%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
5.24K
+778.00%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
5.22K
+759.00%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
3.85K
+962.00%

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
사업별USD
이름
수익
비율
U.S.Omnipod
497.10M
70.38%
International Omnipod
202.10M
28.61%
Drug Delivery
7.10M
1.01%
지역별USD
이름
수익
비율
United States
504.20M
71.39%
All Other
202.10M
28.61%
사업별
지역별
사업별USD
이름
수익
비율
U.S.Omnipod
497.10M
70.38%
International Omnipod
202.10M
28.61%
Drug Delivery
7.10M
1.01%

주식 보유 통계

마지막 업데이트: Sat, Jan 10
마지막 업데이트: Sat, Jan 10
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
12.32%
Fidelity Management & Research Company LLC
9.83%
Capital Research Global Investors
6.47%
BlackRock Institutional Trust Company, N.A.
6.29%
State Street Investment Management (US)
4.39%
기타
60.70%
주주
주주
비율
The Vanguard Group, Inc.
12.32%
Fidelity Management & Research Company LLC
9.83%
Capital Research Global Investors
6.47%
BlackRock Institutional Trust Company, N.A.
6.29%
State Street Investment Management (US)
4.39%
기타
60.70%
주주 유형
주주
비율
Investment Advisor
65.60%
Investment Advisor/Hedge Fund
23.74%
Hedge Fund
4.88%
Pension Fund
2.69%
Research Firm
2.52%
Sovereign Wealth Fund
1.57%
Bank and Trust
1.15%
Individual Investor
0.30%
Family Office
0.05%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
1598
71.88M
102.17%
-3.26M
2025Q3
1546
72.07M
102.39%
-3.66M
2025Q2
1541
72.80M
103.47%
-3.81M
2025Q1
1569
72.82M
103.50%
-3.52M
2024Q4
1508
72.57M
103.34%
-4.94M
2024Q3
1436
73.14M
104.31%
-3.15M
2024Q2
1408
72.17M
103.04%
-3.02M
2024Q1
1350
71.60M
102.26%
-3.12M
2023Q4
1320
72.91M
104.42%
-1.52M
2023Q3
1254
72.05M
103.19%
-4.06M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
8.76M
12.46%
+86.58K
+1.00%
Sep 30, 2025
Fidelity Management & Research Company LLC
6.91M
9.83%
+58.10K
+0.85%
Sep 30, 2025
Capital Research Global Investors
4.55M
6.47%
-187.06K
-3.95%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.43M
6.29%
+74.83K
+1.72%
Sep 30, 2025
State Street Investment Management (US)
3.09M
4.39%
+33.93K
+1.11%
Sep 30, 2025
Baillie Gifford & Co.
2.09M
2.97%
-43.37K
-2.03%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.97M
2.79%
+37.85K
+1.96%
Sep 30, 2025
ClearBridge Investments, LLC
1.47M
2.09%
-69.39K
-4.52%
Sep 30, 2025
American Century Investment Management, Inc.
1.41M
2%
+97.19K
+7.42%
Sep 30, 2025
Fidelity International
1.11M
1.58%
-19.10K
-1.69%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Langar Global HealthTech ETF
7.26%
Innovator IBD Breakout Opportunities ETF
4.88%
Global X HealthTech ETF
4.76%
Goldman Sachs Future Health Care Equity ETF
4.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
3.7%
iShares Health Innovation Active ETF
3%
Congress SMid Growth ETF
2.82%
iShares U.S. Medical Devices ETF
2.62%
FT Raymond James Multicap Growth Equity ETF
2.3%
Acruence Active Hedge US Equity ETF
2.27%
더 보기
Langar Global HealthTech ETF
비율7.26%
Innovator IBD Breakout Opportunities ETF
비율4.88%
Global X HealthTech ETF
비율4.76%
Goldman Sachs Future Health Care Equity ETF
비율4.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
비율3.7%
iShares Health Innovation Active ETF
비율3%
Congress SMid Growth ETF
비율2.82%
iShares U.S. Medical Devices ETF
비율2.62%
FT Raymond James Multicap Growth Equity ETF
비율2.3%
Acruence Active Hedge US Equity ETF
비율2.27%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI